Scientists probe deep into tumors to unlock secrets of new cancer therapy
NCT ID NCT06676033
Summary
This study aims to learn how a new immunotherapy drug called epcoritamab works against two types of blood cancer. Researchers will analyze small tissue samples from five invited patients before and during their treatment. The goal is to see how the drug affects cancer cells and the immune system inside tumors, which could help improve future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RICHTER SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.